UniProt ID | GOLM1_HUMAN | |
---|---|---|
UniProt AC | Q8NBJ4 | |
Protein Name | Golgi membrane protein 1 | |
Gene Name | GOLM1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 401 | |
Subcellular Localization |
Golgi apparatus, cis-Golgi network membrane Single-pass type II membrane protein . Early Golgi. Cycles via the cell surface and endosomes upon lumenal pH disruption. |
|
Protein Description | Unknown. Cellular response protein to viral infection.. | |
Protein Sequence | MMGLGNGRRSMKSPPLVLAALVACIIVLGFNYWIASSRSVDLQTRIMELEGRVRRAAAERGAVELKKNEFQGELEKQREQLDKIQSSHNFQLESVNKLYQDEKAVLVNNITTGERLIRVLQDQLKTLQRNYGRLQQDVLQFQKNQTNLERKFSYDLSQCINQMKEVKEQCEERIEEVTKKGNEAVASRDLSENNDQRQQLQALSEPQPRLQAAGLPHTEVPQGKGNVLGNSKSQTPAPSSEVVLDSKRQVEKEETNEIQVVNEEPQRDRLPQEPGREQVVEDRPVGGRGFGGAGELGQTPQVQAALSVSQENPEMEGPERDQLVIPDGQEEEQEAAGEGRNQQKLRGEDDYNMDENEAESETDKQAALAGNDRNIDVFNVEDQKRDTINLLDQREKRNHTL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MMGLGNGR -------CCCCCCCC | 4.30 | 25732826 | |
47 | Sulfoxidation | VDLQTRIMELEGRVR CCHHHHHHHHHHHHH | 4.30 | 21406390 | |
76 | Ubiquitination | EFQGELEKQREQLDK HHHHHHHHHHHHHHH | 68.24 | - | |
83 | 2-Hydroxyisobutyrylation | KQREQLDKIQSSHNF HHHHHHHHHHHHCCC | 51.76 | - | |
86 | Phosphorylation | EQLDKIQSSHNFQLE HHHHHHHHHCCCCHH | 36.72 | 23312004 | |
87 | Phosphorylation | QLDKIQSSHNFQLES HHHHHHHHCCCCHHH | 13.18 | 23312004 | |
109 | N-linked_Glycosylation | EKAVLVNNITTGERL CCEEEEECCCHHHHH | 26.04 | 17623646 | |
109 | N-linked_Glycosylation | EKAVLVNNITTGERL CCEEEEECCCHHHHH | 26.04 | 17623646 | |
111 | O-linked_Glycosylation | AVLVNNITTGERLIR EEEEECCCHHHHHHH | 30.76 | 55832711 | |
115 (in isoform 2) | Ubiquitination | - | 36.44 | 21890473 | |
125 | Ubiquitination | RVLQDQLKTLQRNYG HHHHHHHHHHHHHHH | 41.37 | 2189047 | |
125 (in isoform 1) | Ubiquitination | - | 41.37 | 21890473 | |
144 | N-linked_Glycosylation | DVLQFQKNQTNLERK HHHHHHHCCCCHHHH | 43.03 | 12754519 | |
144 | N-linked_Glycosylation | DVLQFQKNQTNLERK HHHHHHHCCCCHHHH | 43.03 | 12754519 | |
153 | Phosphorylation | TNLERKFSYDLSQCI CCHHHHHHHCHHHHH | 22.29 | 26091039 | |
154 | Phosphorylation | NLERKFSYDLSQCIN CHHHHHHHCHHHHHH | 24.84 | 27080861 | |
164 | Ubiquitination | SQCINQMKEVKEQCE HHHHHHHHHHHHHHH | 49.98 | - | |
187 | Phosphorylation | KGNEAVASRDLSENN HHCHHHHHCCCCCCH | 21.52 | 21955146 | |
191 | Phosphorylation | AVASRDLSENNDQRQ HHHHCCCCCCHHHHH | 42.43 | 29743597 | |
204 | Phosphorylation | RQQLQALSEPQPRLQ HHHHHHHHCCCHHHH | 50.69 | 24505115 | |
218 | O-linked_Glycosylation | QAAGLPHTEVPQGKG HHCCCCCCCCCCCCC | 36.42 | 55823693 | |
231 | Phosphorylation | KGNVLGNSKSQTPAP CCCCCCCCCCCCCCC | 31.70 | 25159151 | |
231 | O-linked_Glycosylation | KGNVLGNSKSQTPAP CCCCCCCCCCCCCCC | 31.70 | 72253631 | |
233 | Phosphorylation | NVLGNSKSQTPAPSS CCCCCCCCCCCCCCC | 38.82 | - | |
233 | O-linked_Glycosylation | NVLGNSKSQTPAPSS CCCCCCCCCCCCCCC | 38.82 | 55827751 | |
235 | O-linked_Glycosylation | LGNSKSQTPAPSSEV CCCCCCCCCCCCCCE | 28.63 | 55827757 | |
235 | Phosphorylation | LGNSKSQTPAPSSEV CCCCCCCCCCCCCCE | 28.63 | - | |
239 | O-linked_Glycosylation | KSQTPAPSSEVVLDS CCCCCCCCCCEEECC | 41.03 | 55827761 | |
239 | Phosphorylation | KSQTPAPSSEVVLDS CCCCCCCCCCEEECC | 41.03 | 26657352 | |
255 | Phosphorylation | RQVEKEETNEIQVVN CCCCHHHCCCEEECC | 38.96 | 19664994 | |
255 | O-linked_Glycosylation | RQVEKEETNEIQVVN CCCCHHHCCCEEECC | 38.96 | OGP | |
299 | Phosphorylation | GAGELGQTPQVQAAL CCCCCCCCHHHHHHH | 17.56 | 20639409 | |
299 | O-linked_Glycosylation | GAGELGQTPQVQAAL CCCCCCCCHHHHHHH | 17.56 | OGP | |
307 | Phosphorylation | PQVQAALSVSQENPE HHHHHHHHCCCCCCC | 18.26 | 30278072 | |
307 | O-linked_Glycosylation | PQVQAALSVSQENPE HHHHHHHHCCCCCCC | 18.26 | OGP | |
309 | Phosphorylation | VQAALSVSQENPEME HHHHHHCCCCCCCCC | 28.53 | 30278072 | |
351 | Phosphorylation | KLRGEDDYNMDENEA HHCCCCCCCCCHHHH | 25.39 | 26657352 | |
360 | Phosphorylation | MDENEAESETDKQAA CCHHHHCCHHHHHHH | 53.49 | 30266825 | |
362 | O-linked_Glycosylation | ENEAESETDKQAALA HHHHCCHHHHHHHHH | 58.75 | OGP | |
362 | Phosphorylation | ENEAESETDKQAALA HHHHCCHHHHHHHHH | 58.75 | 30266825 | |
384 | Acetylation | VFNVEDQKRDTINLL EEECCHHCCCHHHHH | 65.64 | 7666309 | |
398 | N-linked_Glycosylation | LDQREKRNHTL---- HHHHHHHCCCC---- | 43.49 | UniProtKB CARBOHYD |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GOLM1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GOLM1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DCK_HUMAN | DCK | physical | 16169070 | |
DCTN2_HUMAN | DCTN2 | physical | 16169070 | |
EIF3J_HUMAN | EIF3J | physical | 16169070 | |
GEMI7_HUMAN | GEMIN7 | physical | 16169070 | |
CA174_HUMAN | C1orf174 | physical | 16169070 | |
RL13A_HUMAN | RPL13A | physical | 16169070 | |
MED22_HUMAN | MED22 | physical | 16169070 | |
SYT1_HUMAN | SYT1 | physical | 16169070 | |
RFA2_HUMAN | RPA2 | physical | 16169070 | |
FRIH_HUMAN | FTH1 | physical | 16169070 | |
RACK1_HUMAN | GNB2L1 | physical | 16169070 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-109, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-109, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"An initial characterization of the serum phosphoproteome."; Zhou W., Ross M.M., Tessitore A., Ornstein D., Vanmeter A.,Liotta L.A., Petricoin E.F. III; J. Proteome Res. 8:5523-5531(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-255, AND MASSSPECTROMETRY. |